Kenneth A. Newlander

1.5k total citations
14 papers, 537 citations indexed

About

Kenneth A. Newlander is a scholar working on Molecular Biology, Organic Chemistry and Microbiology. According to data from OpenAlex, Kenneth A. Newlander has authored 14 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Microbiology. Recurrent topics in Kenneth A. Newlander's work include Chemical Synthesis and Analysis (7 papers), Antimicrobial agents and applications (4 papers) and Antimicrobial Peptides and Activities (4 papers). Kenneth A. Newlander is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Antimicrobial agents and applications (4 papers) and Antimicrobial Peptides and Activities (4 papers). Kenneth A. Newlander collaborates with scholars based in United States. Kenneth A. Newlander's co-authors include William F. Huffman, Terrance Moore, Stephen Rittenhouse, Mark A. Seefeld, Walter E. DeWolf, David Payne, Martha S. Head, William H. Miller, Cheryl A. Janson and Paul M. Keller and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Kenneth A. Newlander

14 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth A. Newlander United States 10 356 268 124 95 73 14 537
Kieron M. G. O’Connell United Kingdom 8 342 1.0× 373 1.4× 139 1.1× 100 1.1× 42 0.6× 9 694
Maiko Iida Japan 13 208 0.6× 185 0.7× 83 0.7× 72 0.8× 39 0.5× 23 401
David A. Jude United Kingdom 6 109 0.3× 172 0.6× 41 0.3× 39 0.4× 55 0.8× 7 299
Guy Singh United States 13 381 1.1× 523 2.0× 56 0.5× 111 1.2× 133 1.8× 16 856
Varvara Pokrovskaya Israel 8 117 0.3× 259 1.0× 57 0.5× 92 1.0× 49 0.7× 8 388
Sveta Sedelnikova United Kingdom 4 108 0.3× 339 1.3× 40 0.3× 105 1.1× 58 0.8× 7 543
Grace Kaul India 15 398 1.1× 334 1.2× 105 0.8× 91 1.0× 141 1.9× 67 756
Nishad Thamban Chandrika United States 12 280 0.8× 191 0.7× 55 0.4× 54 0.6× 143 2.0× 28 548
Bolin Geng United States 11 254 0.7× 217 0.8× 26 0.2× 101 1.1× 53 0.7× 12 457
Akinori Okano United States 14 493 1.4× 428 1.6× 179 1.4× 142 1.5× 212 2.9× 22 922

Countries citing papers authored by Kenneth A. Newlander

Since Specialization
Citations

This map shows the geographic impact of Kenneth A. Newlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth A. Newlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth A. Newlander more than expected).

Fields of papers citing papers by Kenneth A. Newlander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth A. Newlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth A. Newlander. The network helps show where Kenneth A. Newlander may publish in the future.

Co-authorship network of co-authors of Kenneth A. Newlander

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth A. Newlander. A scholar is included among the top collaborators of Kenneth A. Newlander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth A. Newlander. Kenneth A. Newlander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Seefeld, Mark A., William H. Miller, Kenneth A. Newlander, et al.. (2003). Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK. Journal of Medicinal Chemistry. 46(9). 1627–1635. 133 indexed citations
2.
Fan, Frank, Nicola G. Wallis, Terrance Moore, et al.. (2002). Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates ofStaphylococcus aureus. Antimicrobial Agents and Chemotherapy. 46(11). 3343–3347. 84 indexed citations
3.
Miller, William H., Mark A. Seefeld, Kenneth A. Newlander, et al.. (2002). Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI). Journal of Medicinal Chemistry. 45(15). 3246–3256. 90 indexed citations
4.
Seefeld, Mark A., William H. Miller, Kenneth A. Newlander, et al.. (2001). Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 11(17). 2241–2244. 52 indexed citations
5.
Newlander, Kenneth A., Balan Chenera, Daniel F. Veber, Nelson C. F. Yim, & M. Lane Moore. (1997). Simple Silyl Linker for the Solid Phase Organic Synthesis of Aryl- Containing Molecules. The Journal of Organic Chemistry. 62(20). 6726–6732. 34 indexed citations
6.
Samanen, James M., Chao‐Pin Lee, Philip L. Smith, et al.. (1997). The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists. Advanced Drug Delivery Reviews. 23(1-3). 133–142. 1 indexed citations
7.
Hoog, Susan S., Baoguang Zhao, Evon Winborne, et al.. (1995). A Check on Rational Drug Design: Crystal Structure of a Complex of Human Immunodeficiency Virus Type 1 Protease with a Novel .gamma.-Turn Mimetic Inhibitor. Journal of Medicinal Chemistry. 38(17). 3246–3252. 30 indexed citations
8.
Miller, William H., Thomas W. Ku, Fadia E. Ali, et al.. (1995). Enantiospecific synthesis of SB 214857, a potent, orally active, nonpeptide fibrinogen receptor antagonist. Tetrahedron Letters. 36(52). 9433–9436. 39 indexed citations
9.
Miller, William H., Kenneth A. Newlander, Drake S. Eggleston, & R. Curtis Haltiwanger. (1995). Synthesis of a 2-benzazepine analog of a potent, nonpeptide GPIIb/IIIa antagonist. Tetrahedron Letters. 36(3). 373–376. 9 indexed citations
10.
Callahan, James F., Kenneth A. Newlander, Joelle L. Burgess, et al.. (1993). The use of γ-turn mimetics to define peptide secondary structure. Tetrahedron. 49(17). 3479–3488. 39 indexed citations
11.
Callahan, James F., Kenneth A. Newlander, & William F. Huffman. (1991). A trans olefin replacement of the disulfide bridge found in cyclic peptides: synthesis of 6,6-pentamethylene-2-amino-Δ4,5-suberic acid.. Tetrahedron Letters. 32(49). 7203–7206. 1 indexed citations
12.
Moore, M. Lane, Christine R. Albrightson, B Brickson, et al.. (1988). Dicarbavasopressin antagonist analogs exhibit reduced in vivo agonist activity. Journal of Medicinal Chemistry. 31(8). 1487–1489. 7 indexed citations
13.
Newlander, Kenneth A., et al.. (1988). A Facile and Versatile Synthesis of 2-Substituted Tryptophans asN α-tert- Butyloxycarbonyl Derivatives. Synthesis. 1988(1). 73–76. 12 indexed citations
14.
Callahan, James F., et al.. (1988). Synthesis of 6,6-pentamethylene-2-aminosuberic acid. A key intermediate in the synthesis of dicarba analogs of vasopressin antagonists. The Journal of Organic Chemistry. 53(7). 1527–1530. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026